Strengthening Coordination Across the Social Safety Net for Patients with Addiction
When: Tuesday, June 2, 2020 | 12:30 to 2 p.m. ET
This 90-minute webinar will provide information and guidance on strategies to enhance coordination across the social safety net to prevent an addiction crisis for high-risk and marginalized populations amidst the COVID-19 pandemic. The session will include introductions from Elizabeth Finkelman, Director of the NAM’s Action Collaborative on Countering the U.S. Opioid Epidemic, and Kelly Clark, Immediate Past President of ASAM, followed by presentations from three panelists and moderated Q&A with the webinar audience.
12:30 p.m. ET | Welcome
- Elizabeth Finkelman – Director, Action Collaborative on Countering the U.S. Opioid Epidemic, National Academy of Medicine
- Kelly Clark – Immediate Past President, American Society for Addiction Medicine
12:40 p.m. ET | Panel Presentations
- Yngvild K. Olsen – Medical Director of the Institutes for Behavior Resources Inc/REACH Health Services
- Elizabeth Salisbury-Afshar – Director, Center for Addiction Research and Effective Solutions, American Institutes for Research
- Corey Waller – Principal, Health Management Associates
1:25 p.m. ET | Moderated Discussion and Audience Q&A
Moderator: Kelly Clark
1:55 p.m. ET | Closing Remarks
2 p.m. ET | Adjourn
AMA Credit Designation Statement:
The American Society of Addiction Medicine designates this internet live course for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and National Academy of Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.
NAADAC, the Association for Addiction Professionals:
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for 1.5 Continuing Education (CE) credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
Elizabeth Finkelman, MPP, Senior Program Officer, National Academy of Medicine
Elizabeth Finkelman is a Senior Program Officer in the Office of the President at the National Academy of Medicine. In her role, she directs NAM special projects and initiatives, including the Action Collaborative on Countering the U.S. Opioid Epidemic, the Healthy Longevity Global Competition, and previously, the Vital Directions for Health and Health Care initiative. Prior to joining the NAM in 2015, Elizabeth spent several years working in program administration and research within the Division on Earth and Life Studies at the National Academies. She completed her undergraduate degree at McGill University, double majoring in cell and molecular biology and political science. Elizabeth has a Master of Public Policy degree from the George Washington University with a concentration in health policy.
Kelly J. Clark, MD, MBA, Immediate Past President, American Society of Addiction Medicine
Kelly J. Clark, MD, MBA, DFAPA, DFASAM currently serves as President of the American Society of Addiction Medicine, the largest group of physicians specializing in addiction in the country with over 5,500 addiction physician specialists and allied health professionals. In addition to direct clinical practice, Kelly has focused her career on issues of addictive disease, evidence informed and quality behavioral health care, and payment reform. Board certified in both psychiatry and addiction medicine, Clark founded Addiction Crisis Solutions to provide both consulting and education of all stakeholder groups in the service of transforming addiction care into evidence-based, cost-effective practice. Dr. Clark’s previous work includes roles as CMO of CleanSlate Centers, CMO of Behavioral Health Group, medical director at CVS Caremark focusing on overutilization of controlled substances, and the behavioral health medical director lead for the in-sourcing of that benefit at Capitol District Physician’s Health Plan. A frequent speaker and addiction policy contributor, she has provided expertise about the opioid crisis to the US Presidential Opioid Commission, FDA, SAMHSA, the Office of Comptroller General; the Pew Trusts, National Safety Council, and National Business Group on Health; as well as numerous provider and payer organizations. Clark earned her MBA from the Fuqua School of Business at Duke University with additional Certification in Health Sector Management, her Doctor of Medicine degree from the University of Wisconsin, and a BA from Coe College.
Dr. Yngvild Olsen graduated from Harvard Medical School in 1997, from the residency training program in internal medicine at Boston Medical Center in 2000, and from the Fellowship in General Internal Medicine at the Johns Hopkins School of Medicine in 2001. From July 2000 through June 2001, she served as Primary Care Chief Resident at Boston Medical Center. During her fellowship, she received a Masters in Public Health from the Johns Hopkins University Bloomberg School of Public Health. Dr. Olsen currently serves as Medical Director of the Institutes for Behavior Resources Inc/REACH Health Services in Baltimore City. This is an outpatient substance use disorder treatment program that provides a broad range of services and includes a health home. She has previously served as the Vice President of Clinical Affairs for the Baltimore Substance Abuse Systems, where she played a central role in the expansion of buprenorphine treatment for opioid addiction in both the treatment and medical systems. She also has served as the Deputy Health Officer for the Harford County Health Department, where she oversaw local substance use treatment services, and as the Medical Director for the Johns Hopkins Hospital’s outpatient substance use treatment services. Dr. Olsen has written and lectured extensively on opioid use disorder and its treatments. She has published in numerous journals, including the Journal of the American Medical Association, the New England Journal of Medicine, and the Journal of Addictive Diseases, on such topics as smoking in substance use treatment programs, the public health impact of buprenorphine treatment expansion, the stigma associated with medication-assisted treatment, and the dual challenges of pain treatment and addiction. As an addiction medicine specialist trained in internal medicine, she teaches appropriate opioid prescribing to primary care physicians and instructs on medical co-occurring conditions to psychiatrists and other behavioral health providers. Dr. Olsen currently serves as Secretary to the ASAM Board of Directors and a member of the Public Policy Committee. She is the Immediate Past President of the Maryland Society of Addiction Medicine, Immediate Past President of the Maryland Association for the Treatment of Opioid Dependence, and a Board member of the National Council on Alcoholism and Drug Dependence-MD (NCADD-MD).
Elizabeth Salisbury-Afshar, MD, MPH, Director, Center for Addiction Research and Effective Solutions, American Institutes for Research
Elizabeth Salisbury is the Director of the Center for Multi-System Solutions to the Opioid Epidemic at the American Institute for Research, a nonprofit social and behavioral sciences research organization. Dr. Salisbury-Afshar is board certified in family medicine, preventive medicine/public health and addiction medicine and her expertise lies at the intersection of these fields. Past roles include serving as the Medical Director of Behavioral Health Systems Baltimore, a quasi-public entity that oversees all publicly funded addiction and mental health treatment and as the Medical Director of Behavioral Health at the Chicago Department of Public Health. She has over nine years of experience working clinically in federally qualified health centers- providing direct patient care in both primary care and addiction medicine. She previously served as the Medical Director of Heartland Alliance Health, a healthcare for the homeless provider in Chicago, and she continues to work in this clinic on a part-time basis and provides primary care and addiction treatment services. Dr. Salisbury-Afshar received her Medical Degree from Rush University Medical College and her Master’s in Public Health from John Hopkins Bloomberg School of Public Health.
Corey Waller, MD, MS, Principal, Health Management Associates
R. Corey Waller MD, MS, FACEP, DFASAM is an addiction, pain, and emergency medicine specialist now a Principal Consultant at Health Management Associates (HMA) and Chair of the Legislative Advocacy Committee for the American Society of Addiction Medicine (ASAM). In these roles he is directly responsible for Consultation regarding Addiction treatment eco-system development and education as well as all Washington DC-related matters for ASAM. In his immediate past role of Senior Medical Director for Education and Policy at the National Center for Complex Health and Social Needs he was responsible for developing and maintaining all training and in person technical assistance delivered by the National Center. This covered addiction, pain and behavioral health treatment system development, payment model implementation and healthcare policy. Before joining the National Center, he worked for the Spectrum Health System in Grand Rapids, Michigan, which is a fully integrated health system with 12 hospitals and over 1000 employed physicians. He was the Medical Director of the Spectrum Health Medical Group Center for Integrative Medicine, the Medical Staff Chief of Pain Medicine to the Spectrum Health Hospital System, the President of the Michigan Society of Addiction Medicine, as well as Substance Use Disorder Medical Director at Lakeshore Regional Partners (Community Mental Health-Region 3). Dr. Waller has also worked extensively with local, state and Federal law enforcement on the issues of controlled substance diversion and interdiction. Dr. Waller earned a Master of Science in Biology with a neuro-molecular focus at Southwest Texas State University and earned his Medical Degree at the University of Texas Medical School in San Antonio. Dr. Waller completed his Emergency Medicine residency at Thomas Jefferson University in Philadelphia and is board Certified in Emergency Medicine and Addiction Medicine.
This webinar is the third in a series called “Supporting People With Addiction During COVID-19”, hosted by the National Academy of Medicine and the American Society for Addiction Medicine.
Questions? Please contact email@example.com
Join our U.S. Opioid Epidemic listserv to be notified of new resources and upcoming events.